07.01.2013 Views

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

TCMPF<br />

60588<br />

LYMPHOCYTE RATIO<br />

H/S ratio: > or =1.0<br />

*Shearer WT, Rosenblatt HM, Gelman RS, et al: Lymphocyte subsets in healthy children from birth<br />

through 18 years of age: The Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol<br />

2003;112(5):973-980<br />

LYMPHOCYTE PROLIFERATION TO ANTIGENS<br />

Viability of lymphocytes at day 0: > or =75.0%<br />

Maximum proliferation of Candida albicans as % CD45: > or =5.7%<br />

Maximum proliferation of Candida albicans as % CD3: > or =3.0%<br />

Maximum proliferation of tetanus toxoid as % CD45: > or =5.2%<br />

Maximum proliferation of tetanus toxoid as % CD3: > or =3.3%<br />

Clinical References: See individual test IDs.<br />

T- and B-Cell Quantitation and Lymphocyte Proliferation to<br />

Mitogens Panel<br />

Clinical Information: See individual test IDs.<br />

Useful For: Assessing global T-cell function and quantitating lymphocyte subsets in a single orderable<br />

test. This panel is most helpful when evaluating patients with immunodeficiencies, where quantitative<br />

decreases in T cells can lead to reduced functional mitogen responses. See individual test IDs for<br />

additional information.<br />

Interpretation: Since the presence of lymphopenia, particularly in the T-cell compartment, can reduce<br />

the magnitude of the proliferative response to antigens, it is helpful to perform simultaneous numerical<br />

evaluation of lymphocyte subsets to aid in interpretation of the functional (proliferation) data. See<br />

individual test IDs for additional information.<br />

Reference Values:<br />

T- AND B-CELL QUANTIATION BY FLOW CYTOMETRY<br />

T AND B SURFACE MARKER<br />

% T Cells (CD3)<br />

0-2 months: 53-84%*<br />

3-5 months: 51-77%*<br />

6-11 months: 49-76%*<br />

12-23 months: 53-75%*<br />

2-5 years: 56-75%*<br />

6-11 years: 60-76%*<br />

12-17 years: 56-84%*<br />

18-55 years: 59-83%<br />

>55 years: 49-87%<br />

% B Cells (CD19)<br />

0-2 months: 6-32%*<br />

3-5 months: 11-41%*<br />

6-11 months: 14-37%*<br />

12-23 months: 16-35%*<br />

2-5 years: 14-33%*<br />

6-11 years: 13-27%*<br />

12-17 years: 6-23%*<br />

18-55 years: 6-22%<br />

>55 years: 3-20%<br />

% Natural Killer (CD16+CD56)<br />

Current as of January 3, 2013 2:22 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong>Laboratories.com Page 1684

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!